◆ 会议时间：2022年3月11日至13日
◆ 会议地点：日本 神户（Kobe）

◆ 会议简介：

2022年第86届日本循环器学会(JCS)年度科学会议将于2022年3月11日至13日在日本神户举行。本次会议将与亚太心脏病学会(APSC)大会同期举行。JCS年会是世界上最大的单一国家心脏病学会议之一，每年有超过15000人参加。

日本循环器学会(JCS)是日本及至世界上最负盛名的心血管疾病专业医学学会之一，现拥有超过26000名成员。JCS有着80多年的悠久历史，1935年日本临床心血管病学杂志创刊，1936年日本临床心血管病学会成立，1953年学会和期刊更名日本循环器学会（期刊）。JCS的业务范围广泛，包括发行期刊、制定指南和组织科学会议。JCS年度科学会议有约20,000名参与者。JCS还与AHA，ACC，ESC，韩国心脏病学会（KSC）和中国心脏病学会（CSC）等国外心脏病学会联合举办研讨会，并与亚洲国家相关组织宣合作开展临床试验和研究。未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

第86回日本循環器学会学術集会（JCS2022）
The 86th Annual Scientific Meeting of the Japanese Circulation Society (JCS2022)

Dates/时间：
March 11 (Fri.) - 13 (Sun.), 2022

Venue/会场：
- Kobe International Conference Center
- Kobe International Exhibition Hall
- Kobe Portopia Hotel

Theme/主题：
ウィングを広げる循環器病学
Cardiology Spreading Its Wings

摘要提交：

Plenary Sessions and Symposia
Regular Abstracts
Case Report Session
Late Breaking (Clinical Trials / Cohort Studies)

Plenary Sessions and Symposia

Deadline for Initial Submission: Thursday, August 5, 2021, 06:00AM (JST)
Deadline for Revision: Friday, August 6, 2021, 06:00AM (JST)、

Regular Abstracts

Deadline for Initial Submission: Tuesday, September 14, 2021, 06:00AM (JST)
Extended Deadline for Initial Submission: Thursday, September 16, 2021, 06:00AM (JST)
Deadline for Revision: Thursday, September 16, 2021, 06:00AM (JST)

Case Report Session

Deadline for Initial Submission: Tuesday, September 14, 2021, 06:00AM (JST)
Extended Deadline for Initial Submission: Thursday, September 16, 2021, 06:00AM (JST)
Deadline for Revision: Thursday, September 16, 2021, 06:00AM (JST)

Late Breaking (Clinical Trials / Cohort Studies)

Abstract Submission Starts: Thursday, August 5, 2021, 10:00AM (JST)
Deadline for Revision: Thursday, September 16, 2021, 06:00AM (JST)

Welcome Greeting

The 86th Annual Scientific Meeting of the Japanese Circulation Society (JCS 2022) will be held on March 11–13, 2022 at the Kobe International Conference Center, Kobe Portopia Hotel, and Kobe International Exhibition Hall. This year, the meeting will be held jointly with the Asian Pacific Society of Cardiology (APSC) Congress 2022, which is chaired by Professor Takashi Akasaka of the Department of Cardiovascular Medicine of Wakayama Medical University. This will be first Annual Scientific Meeting to be held following the Covid-19 pandemic, and we intend to hold it mainly onsite, while also making the proceedings available online in a hybrid format.

Much has changed as a result of the Covid-19 pandemic. Holding scientific meetings online has become the mainstream worldwide. The Internet is an excellent method of transmitting information, and as it has the advantages of not being subject to time constraints, not requiring travel, and costing less, this method has become extremely popular.

However, holding scientific meetings onsite expands participants’ networks by giving them the experience of meeting face-to-face and debating each other directly, allowing them to hear words of direct encouragement from their seniors, letting them communicate with distant friends, giving them the opportunity of chatting in corridors, and letting them feel the excitement of speaking in person with researchers doing great work around the world. I am also very much looking forward to networking with Asian researchers as a result of holding this meeting in conjunction with APSC 2022. Covid-19 has renewed our awareness of the importance of person-to-person interactions.

The theme of this Annual Meeting is “Cardiology Spreading its Wings.” The number of patients with heart failure and other cardiovascular diseases is increasing dramatically, and the fields dealt with by cardiovascular medicine are also massively expanding. Chronic kidney disease, diabetes mellitus, chronic obstructive pulmonary disease, malignant tumors, and frailty are just some of the comorbidities involving other departments that are experienced by older patients, and it is now clear that these comorbidities exacerbate heart disease. Adult congenital heart disease and onco-cardiology are among the new areas with which we are required to deal. New genome editing, iPS cells, molecular targeted drugs, big data, artificial intelligence, and novel devices are all among the fields that will bring about major transformations of cardiovascular medicine in future. In addition to plenary sessions and symposia covering these fields, we are planning a program that will also include in-depth debates on issues where opinions differ, sessions providing the latest information on various topics, and meet-the-expert sessions for discussions with experts in different fields, making this Annual Meeting both intellectually satisfying and exciting for participants.

For cardiovascular medicine to be able to cope with this rapidly expanding range of fields, we will have to create new worlds in both healthcare and academia while maintaining the traditions we have inherited. I hope that this Annual Meeting will be an opportunity for members of different cardiology-related professions to attend from all over the world, express their opinions in discussion, and start to sketch out the new future of cardiovascular medicine. Academic meetings are made by their participants. I hope you will consider attending this Annual Meeting in person and adding your voice to the discussion.

Hiroshi Ito, M.D., Ph.D., FACC, FESC, FJCS
Congress Chairperson of the 86th Annual Scientific Meeting of the Japanese Circulation Society
(Professor, Department of Cardiovascular Medicine, Okayama University)

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。